Charles E. Sparks

4.8k total citations
102 papers, 3.7k citations indexed

About

Charles E. Sparks is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Charles E. Sparks has authored 102 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Molecular Biology and 31 papers in Surgery. Recurrent topics in Charles E. Sparks's work include Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Lipoproteins and Cardiovascular Health (20 papers) and Liver Disease Diagnosis and Treatment (13 papers). Charles E. Sparks is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Lipoproteins and Cardiovascular Health (20 papers) and Liver Disease Diagnosis and Treatment (13 papers). Charles E. Sparks collaborates with scholars based in United States, Netherlands and United Kingdom. Charles E. Sparks's co-authors include Janet D. Sparks, James P. Corsetti, Julian B. Marsh, Mary Bolognino, Harold C. Smith, Khosrow Adeli, Wojciech Zaręba, Thuy L. Phung, Joanne Cianci and Arthur J. Moss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Charles E. Sparks

102 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Sparks United States 35 1.5k 1.3k 1.1k 941 657 102 3.7k
B H Chung United States 31 1.1k 0.8× 1.1k 0.8× 1.1k 1.0× 636 0.7× 498 0.8× 52 3.4k
S.‐O. Olofsson Sweden 24 989 0.7× 1.1k 0.9× 797 0.7× 717 0.8× 784 1.2× 41 3.1k
Kazuhisa Tsukamoto Japan 30 1.6k 1.1× 723 0.6× 960 0.9× 911 1.0× 313 0.5× 103 3.5k
John F. Moorhead United Kingdom 35 1.2k 0.8× 615 0.5× 1.1k 1.0× 902 1.0× 366 0.6× 71 3.9k
Todd G. Kirchgessner United States 36 1.8k 1.2× 979 0.8× 1.2k 1.2× 688 0.7× 1.2k 1.8× 43 5.1k
Ewa Ninio France 37 1.4k 0.9× 570 0.5× 1.2k 1.1× 748 0.8× 576 0.9× 103 4.1k
Mitsuyo Okazaki Japan 32 1.1k 0.7× 1.2k 1.0× 1.3k 1.2× 520 0.6× 702 1.1× 92 3.2k
T.G. Redgrave Australia 30 1.0k 0.7× 1.5k 1.2× 1.3k 1.2× 471 0.5× 714 1.1× 73 3.8k
Eva Hurt‐Camejo Sweden 42 1.8k 1.2× 843 0.7× 1.5k 1.4× 793 0.8× 623 0.9× 92 4.8k
P. Haydn Pritchard Canada 38 1.5k 1.0× 1.2k 1.0× 1.9k 1.8× 433 0.5× 337 0.5× 111 4.3k

Countries citing papers authored by Charles E. Sparks

Since Specialization
Citations

This map shows the geographic impact of Charles E. Sparks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Sparks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Sparks more than expected).

Fields of papers citing papers by Charles E. Sparks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Sparks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Sparks. The network helps show where Charles E. Sparks may publish in the future.

Co-authorship network of co-authors of Charles E. Sparks

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Sparks. A scholar is included among the top collaborators of Charles E. Sparks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Sparks. Charles E. Sparks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corsetti, James P., Charles E. Sparks, Stephan J. L. Bakker, Eke G. Gruppen, & Robin P. F. Dullaart. (2017). Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects. Clinical Biochemistry. 52. 67–72. 7 indexed citations
2.
Jenkins, Jermaine L., Yan Wang, Wayne C. Guida, et al.. (2016). Phosphatidylinositol (3,4,5)-trisphosphate binds to sortilin and competes with neurotensin: Implications for very low density lipoprotein binding. Biochemical and Biophysical Research Communications. 479(3). 551–556. 8 indexed citations
3.
Guida, Wayne C., Mark P. Sowden, Jermaine L. Jenkins, et al.. (2016). Sortilin facilitates VLDL-B100 secretion by insulin sensitive McArdle RH7777 cells. Biochemical and Biophysical Research Communications. 478(2). 546–552. 10 indexed citations
4.
5.
Szepietowska, Barbara, Scott McNitt, Valentina Kutyifa, et al.. (2015). Insulin resistance predicts the risk for recurrent coronary events in post-infarction patients. Cardiology Journal. 22(5). 519–526. 4 indexed citations
6.
Corsetti, James P., Ron T. Gansevoort, Stephan J. L. Bakker, et al.. (2014). Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants. Journal of the American Society of Nephrology. 25(12). 2906–2915. 16 indexed citations
7.
Sparks, Janet D., et al.. (2011). Acute suppression of apo B secretion by insulin occurs independently of MTP. Biochemical and Biophysical Research Communications. 406(2). 252–256. 19 indexed citations
8.
Corsetti, James P., Ron T. Gansevoort, Gerjan Navis, Charles E. Sparks, & Robin P.F. Dullaart. (2010). LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis. 214(2). 373–376. 18 indexed citations
9.
Corsetti, James P., David L. Rainwater, Arthur J. Moss, et al.. (2008). Lp(a) and Risk of Recurrent Cardiac Events in Obese Postinfarction Patients. Obesity. 16(12). 2717–2722. 7 indexed citations
10.
Moss, Arthur J., Daniel H. Ryan, David Oakes, et al.. (2005). Atherosclerotic Risk Genotypes and Recurrent Coronary Events After Myocardial Infarction. The American Journal of Cardiology. 96(2). 177–182. 13 indexed citations
11.
Collins, Heidi L., et al.. (2004). Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats. American Journal of Physiology-Endocrinology and Metabolism. 287(1). E42–E49. 23 indexed citations
12.
Collins, Heidi L., Charles E. Sparks, & Janet D. Sparks. (2000). B48 Is Preferentially Translated over B100 in Cells with Increased Endogenous Apo B mRNA. Biochemical and Biophysical Research Communications. 273(3). 1156–1160. 6 indexed citations
13.
Sparks, Janet D., Thuy L. Phung, Mary Bolognino, et al.. (1998). Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: Hyperinsulinemic versus insulinopenic hyperglycemia. Metabolism. 47(11). 1315–1324. 42 indexed citations
14.
Mater, David Van, Mark P. Sowden, Joanne Cianci, et al.. (1998). Ethanol Increases Apolipoprotein B mRNA Editing in Rat Primary Hepatocytes and McArdle Cells. Biochemical and Biophysical Research Communications. 252(2). 334–339. 20 indexed citations
15.
Valentine, J. L., R. Middleton, & Charles E. Sparks. (1996). Identification of Urinary Benzodiazepines and their Metabolites: Comparison of Automated HPLC and GC-MS after Immunoassay Screening of Clinical Specimens. Journal of Analytical Toxicology. 20(6). 416–424. 52 indexed citations
16.
Sparks, Janet D. & Charles E. Sparks. (1994). Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1215(1-2). 9–32. 177 indexed citations
17.
Sparks, Janet D. & Charles E. Sparks. (1994). Obese Zucker (fa/fa) Rats Are Resistant to Insulin′s Inhibitory Effect on Hepatic APO B Secretion. Biochemical and Biophysical Research Communications. 205(1). 417–422. 43 indexed citations
18.
Backus, John W., et al.. (1993). Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins.. Journal of Biological Chemistry. 268(10). 7382–7392. 98 indexed citations
19.
Greenland, Philip, et al.. (1990). Precision and accuracy of a portable blood analyzer system during cholesterol screening.. American Journal of Public Health. 80(2). 181–184. 6 indexed citations
20.
Eskin, Bernard A., Charles E. Sparks, & Bruce I. LaMont. (1979). The intracellular metabolism of iodine in carcinogenesis. Biological Trace Element Research. 1(2). 101–117. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B H Chung Breakdown of academic impact, for papers by S.‐O. Olofsson Breakdown of academic impact, for papers by Kazuhisa Tsukamoto Breakdown of academic impact, for papers by John F. Moorhead Breakdown of academic impact, for papers by Todd G. Kirchgessner Breakdown of academic impact, for papers by Ewa Ninio Breakdown of academic impact, for papers by Mitsuyo Okazaki Breakdown of academic impact, for papers by T.G. Redgrave Breakdown of academic impact, for papers by Eva Hurt‐Camejo Breakdown of academic impact, for papers by P. Haydn Pritchard
Rankless by CCL
2026